Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
about
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation.Non-vitamin K antagonist oral anticoagulants in atrial fibrillation and venous thromboembolism: where are we now?Management of rivaroxaban in relation to bodyweight and body mass index.Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review.Rivaroxaban for a Patient with Class III Obesity: Case Report with Literature Review.
P2860
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
@en
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
@nl
type
label
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
@en
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
@nl
prefLabel
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
@en
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
@nl
P2093
P2860
P1476
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
@en
P2093
Adrian Mahlmann
Jan Beyer-Westendorf
Siegmund Gehrisch
P2860
P2888
P304
P356
10.1007/S11239-013-0891-2
P577
2013-11-01T00:00:00Z
P6179
1010105530